PAI

Palo Alto Investors Portfolio holdings

AUM $470M
1-Year Return 2.57%
This Quarter Return
+57.27%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.67B
AUM Growth
+$471M
Cap. Flow
-$70.6M
Cap. Flow %
-4.24%
Top 10 Hldgs %
75.81%
Holding
42
New
5
Increased
4
Reduced
20
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ZGNX
26
DELISTED
Zogenix, Inc.
ZGNX
$2.81M 0.17%
104,100
+74,600
+253% +$2.02M
GOSS icon
27
Gossamer Bio
GOSS
$787M
$2.66M 0.16%
+204,214
New +$2.66M
ATNX
28
DELISTED
Athenex, Inc. Common Stock
ATNX
$2.55M 0.15%
+9,260
New +$2.55M
SNDX icon
29
Syndax Pharmaceuticals
SNDX
$1.34B
$1.89M 0.11%
127,700
+61,600
+93% +$913K
APRE icon
30
Aprea Therapeutics
APRE
$8.99M
$1.83M 0.11%
+2,362
New +$1.83M
DNTH icon
31
Dianthus Therapeutics
DNTH
$1.48B
$1.46M 0.09%
+12,163
New +$1.46M
ALIM
32
DELISTED
Alimera Sciences, Inc.
ALIM
$1.27M 0.08%
200,919
KZR icon
33
Kezar Life Sciences
KZR
$28.9M
$1.06M 0.06%
+20,509
New +$1.06M
ITCI
34
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$960K 0.06%
37,400
TVTX icon
35
Travere Therapeutics
TVTX
$2.09B
$959K 0.06%
47,000
URGN icon
36
UroGen Pharma
URGN
$869M
$640K 0.04%
24,500
MRNS
37
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$318K 0.02%
31,330
ALDX icon
38
Aldeyra Therapeutics
ALDX
$324M
$306K 0.02%
73,500
VIRX
39
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$306K 0.02%
33,214
ACGN
40
DELISTED
Aceragen, Inc. Common Stock
ACGN
$138K 0.01%
4,537
NERV icon
41
Minerva Neurosciences
NERV
$15.2M
$131K 0.01%
4,540
WMGI
42
DELISTED
Wright Medical Group Inc
WMGI
-242,940
Closed -$6.96M